About
Pharmaceutical Services
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ResearchContract ManufacturingContract ManufacturingContract ResearchContract ResearchContract ResearchContract ManufacturingContract ManufacturingContract ManufacturingContract ManufacturingNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
492
By Phase
PHASE2: 2PHASE4: 2
By Status
COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05280314Collaborator
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
PHASE2Recruiting
60 participants
Started: Dec 21, 2023 · Completed: Jan 31, 2027
NCT05721235Collaborator
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
PHASE4Completed
123 participants
Started: Jun 2, 2023 · Completed: Aug 29, 2025
NCT05685732Collaborator
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
PHASE4Completed
246 participants
Started: Mar 22, 2023 · Completed: May 2, 2024
NCT05077709Collaborator
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
PHASE2Active, not recruiting
63 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2024
Locations (1)
Headquarters
Souderton, PA, United States
Map
Loading map...